Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12â300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial
Castro, Nathalie de; Marcy, Olivier; Chazallon, Corine; Messou, Eugène; Eholié, Serge; N'takpe, Jean-Baptiste; Bhatt, Nilesh; Khosa, Celso; Massango, Isabel Timana; Laureillard, Didier; Chau, Giang do; Domergue, Anaïs; Veloso, Valdiléa G.; Escada, Rodrigo; Cardoso, Sandra W.; Delaugerre, Constance; Anglaret, Xavier; Molina, Jean-Michel; Grinsztejn, Beatriz; ANRS 12300 Reflate TB2 study group.
Artículo
en Inglés
| ARCA | ID: arc-50476
Texto completo
Documentos relacionados